Considering the abundance of PPARγ receptor and elevated NHE1 expression in a variety of cancer cells including breast cancer and their absolute dependence on MnSOD it is of interest to explore PPARγ agonists for selectively tailoring the expression of NHE1 and MnSOD. This evidence concerns the gene SLC9A1 and breast carcinoma.